401 Episodes

  1. Episode 223: ASCO GU 2023: Discussing KEYNOTE-057 with Andrea Necchi, MD

    Published: 2/17/2023
  2. Episode 222: ASCO GU 2023: New Data From IMvigor130 with Enrique Grande, MD

    Published: 2/17/2023
  3. Episode 221: ASCO GU 2023: Matt Galsky, MD Gives an Update on the CheckMate 274 Trial

    Published: 2/17/2023
  4. Episode 220: ASCO GU 2023: Discussing PARPi for CRPC with Michael Morris, MD

    Published: 2/17/2023
  5. Episode 219: ASCO GU 2023: Neeraj Agarwal, MD, FASCO Discusses the TALAPRO-2 study

    Published: 2/17/2023
  6. Episode 218: Discussing The Cost of Cancer Drugs With Daniel Goldstein, MD

    Published: 2/7/2023
  7. Episode 217: Rising Star: Vadim Koshkin and ADCs

    Published: 2/3/2023
  8. Episode 216: ADCs in Bladder Cancer With Petros Grivas, MD, PhD

    Published: 1/30/2023
  9. Episode 215: Resumen cáncer de próstata y vejiga reunión Canarias

    Published: 1/21/2023
  10. Episode 214: Resumen de la reunión en las Islas Canarias sobre cáncer renal

    Published: 1/21/2023
  11. Episode 213: IL-15RaFc superagonist in NMIBC

    Published: 1/9/2023
  12. Episode 212: What's coming in GU Cancers in 2023

    Published: 1/2/2023
  13. Episode 211: CAR-T cell therapy in RCC

    Published: 12/29/2022
  14. Episode 210: Christmas Prostate Cancer Debate - olaparib and abiraterone in selected or unselected patients

    Published: 12/22/2022
  15. Episode 209: Christmas Bladder Cancer Debate - Cisplatin vs carboplatin in bladder cancer

    Published: 12/17/2022
  16. Episode 208: Christmas Kidney Cancer Debate - Ipilimumab in renal cancer

    Published: 12/12/2022
  17. Episode 207: Editorial on COSMIC-313

    Published: 12/5/2022
  18. Episode 206: Dan Shapiro in the Rising Star series

    Published: 11/28/2022
  19. Episode 205: Paper of the Month - Nab-paclitaxel and pembrolizumab in bladder cancer

    Published: 11/21/2022
  20. Episode 204: Scott Haake in the Rising Star series

    Published: 11/14/2022

10 / 21

Broadcasting the latest developments in GU cancer Hosted by Brian Rini and Tom Powles Brian Rini MD is a Professor of Cancer Research and Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London